18.01.2013 - British vaccine specialist PsiOxus Therapeutics Ltd. has baged a US$3.3m development contract from US Defense Threat Reduction Agency.
Under the terms of the agreement, the Oxford-based company will develop biodefence vaccine adjuvants. Using its PolyMAP platform, the company’s research will be aimed at improving safety and efficacy of two existing vaccine candidates: the recombinant protective antigen (rPA) against Anthrax and the Venezuelan Equine Encephalopathy Virus (VEEV). A monoclonal antibody targeting Anthrax has been recently approved by the US FDA.
The contract will support work over a three-year period in the US, as well as in the company’s new laboratory in Oxford, which has been designed and equipped as a category two laboratory for the handling of live viruses.
PsiOxus Therapeutics’ PolyMAP technology links polymers to synthetic adjuvants that activate specific sets of Toll-like receptors (TRLs), which significantly boosts the effectiveness of vaccines in a controlled manner.
25.08.2015 Oslo Cancer Cluster is inaugurating its NOK1bn (€107m) Innovation Park. None other than Norwegian prime minister Erna Solberg officially opened the doors to the research park on August 24th.
21.08.2015 Novartis Pharma AG has secured all remaining rights to antibody hopeful ofatumumab. Seller GlaxoSmithKline is set to receive up to US$1bn (€919m) for the treatment for MS and other autoimmune indications.
11.08.2015 Biotech bug controllers Oxitec has been bought by US biotech Intrexon Corporation for $160m (€145m). The Oxford University spin-out specialises in environmentally friendly technology to control pests such as mosquitoes, which cause dengue fever and other diseases.
04.08.2015 In a deal worth US$65m upfront, AstraZeneca is again teaming up with long-time partner Isis Pharmaceuticals Inc., this time to discover and develop RNA antisense drugs for cardiovascular, metabolic and renal diseases.
The BioShake series contains high-speed mixer and thermal mixer for small and very small volumes in microplates and reaction tubes and allows for the first time high precise and efficient mixing in the microliter scale for a wide range of applications. more